PDCD1 and neoplasm: Previously, we reported that elevated tumoral KYNU expression was associated with an immunosuppressive tumor microenvironment, characterized by increased signatures of regulatory T-cells (Tregs) as well as immune checkpoint blockade genes PD-1 and PD-L1 in LUAD and that elevated tumoral KYNU expression was prognostic for poor overall survival [3].